All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia

Blood

Volumn 85, Issue 10, 1995, Pages 2643-2653

  Degos, Laurent ^a   Dombret, Hervé ^b   Chomienne, Christine ^b   Daniel, Marie Thérèse ^b   Micléa, Jean Michel ^b   Chastang, Claude ^b   Castaigne, Sylvie ^b   Penaux, Pierre ^b  

^a UNIVERSITÉ PARIS DIDEROT   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; BLAST CELL; BLOOD CLOTTING DISORDER; CELL DIFFERENTIATION; CHROMOSOME TRANSLOCATION 15; DRUG RESISTANCE; ERYTHEMA NODOSUM; HEADACHE; HUMAN; HYPERCALCEMIA; PRIORITY JOURNAL; RECEPTOR GENE; RELAPSE; REVIEW;

EID: 0028999532     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v85.10.2643.bloodjournal85102643     Document Type: Review

References (115)

1. Bennett JM, Catowsky D, Danicr MT, Flandrin G, Galton D, Gralnick M, Sultan C: Proposals for the classification of the acute leukemias. Br J Haematol 33:451, 1976
2. Bennet JM, Catowsky D, Danier MT, Flandrin G, Galton D, Gralnick M, Sultan C: A variant form of hypergranular promyelocytic leukemia (M3). Ann Intern Med 92:280, 1980
3. Larson RA, Kondo K, Vardiman JW, Butler ARE, Golomb HM, Rowley JD: Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med 76:827, 1984
4. De The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A: The PML-RAR alpha fusion mRNA generated by the t(15; 17) translocation in.acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675, 1991
5. Kakizuka A, Miller WH, Umesono K, Warrell R, Frankel S, Dmitrovsky E, Evans R: Chromosomal translocation t(15; 17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66:663, 1991
6. Tallman MS, Kwaan HC: Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood 79:543, 1992
7. Dombret H, Sutton L, Duarte M, Daniel MT, Leblond V, Castaigne S, Degos L: Combined therapy with all-trans retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage. Leukemia 6:1237, 1992
8. Bernard J, Weil B, Boiron M, Aucleic-Gemon MF, Jacquillat C: Acute promyelocytic leukemia. Results of treatment with daunorubicin. Blood 41:489, 1973
9. Marty M, Ganem G, Fischer J, Flandrin G, Berger R, Schaison G, Degos L, Boiron M: Leucémie aiguë promyélocytaire: Étude rétrospective de 119 malades traités par daunorubicine. Nouv Rev Fr Hematol 24:371, 1984
10. Kantarjian H, Keating M, Walters R: Acute promyelocytic leukemia. MD Anderson Hospital Experience. Am J Med 80:789, 1986
11. Cunningham I, Gee T, Reich L: Acute promyelocytic leukemia: Treatment results during a decade at Memorial Hospital. Blood 73:1116, 1989
12. Sanz M, Jarque I, Martin G: Acute promyelocytic leukemia. Therapy results and prognostic factors. Cancer 61:7, 1988
13. Cordonnier C, Vernant JP, Brun B: Acute promyelocytic leukemia in 57 previously untreated patients. Cancer 55:18, 1985
14. Fenaux P, Pollet JP, Vandenbossche L, Dupriez B, Jouet JP, Bauters F: Treatment of acute promyelocytic leukemia: a report on 70 cases. Leuk Lymphoma 4:249, 1991
15. Fenaux P, Tertian G, Castaigne S: A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia. J Clin Oncol 9:1556, 1991
16. Rodighiero F, Avvisati G, Castaman G, Mandelli F: Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEmA retrospective study in 268 consecutive patients. Blood 11:2112, 1990
17. Hoyle C, Swirsky D, Freedman L, Hayhoe F: Beneficial effect of heparin in the management of patients with APL. Br J Haematol 68:283, 1988
18. Goldberg MA, Ginsburg D, Mayer RJ, Stone RM, Maguire M, Rosenthal DS, Antin JH: Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia? Blood 69:187, 1987
19. Arlin Z, Kempin S, Mertelsmann R: Primary therapy of acute promyelocytic leukemia: Role of Amsacrine and Daunorubicin based therapy. Blood 63:211, 1984
20. Chan KW, Steinherz PG, Miller DR: Acute promyelocytic leukemia in children. Med Pediatr Oncol 9:5, 1981
21. Carter M, Kalwinsky D, Dahl G, Santana VM, Mason CA, Schell MJ: Childhood acute promyelocytic leukemia: A rare variant of nonlymphoid leukemia with distinctive clinical and biological features. Leukemia 4:298, 1989
22. Thomas W, Archimbaud E, Treille-Ritouet D, Fiere D: Prognostic factors in acute promyelocytic leukemia: A retrospective study of 67 cases. Leuk Lymphoma 4:249, 1991
23. Huang M, Yu-Chen Y, Shu-Rong C, Lu MX, Zhoa L, Gu LJ, Wang ZY: Use of all trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567, 1988
24. Chomienne C, Ballerini P, Balitrand N, Daniel MT, Fenaux P, Castaigne S, Degos L: All trans retinoic acid in promyelocytic leukemias. II. In vitro studies structure function relationship. Blood 76:1710, 1990
25. Castaigne S, Chomienne C, Daniel MT, Berger R, Fenaux P, Degos L: All trans retinoic acid as a differentiating therapy for acute promyelocytic leukemias. I. Clinical results. Blood 76:1704, 1990
26. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi P, Donti E, Biondi A, Lo Coco F, Pellici P: Review: Acute promyelocytic leukemia: From genetics to treatment. Blood 83:10, 1994
27. Head D, Kopecky KJ, Willman CL, Appelbaum FR: Aggressive daunomycin (DNR) therapy improves survival in acute promyelocytic leukemia (APL), a Southwest Oncology Group (SWOG trial). Leukemia (in press)
28. Avvisatti G, Petti MC, Latagliata R, Spadea A, Aloe Spiriti MA, Montefusco E, Moleti ML, Meloni G, Arcese W, Mandelli F. Treatment of acute promyelocytic leukemia (APL) by all-trans retinoic acid (ATRA): experience at the hematology of Rome university "La Sapienza". Leukemia (in press)
29. Kantarjian H, Keating M, Walters RS, Smith TL, McCredie KB, Freireich EJ: Role of maintenance chemotherapy in acute promyelocytic leukemia. Cancer 59:1258, 1987
30. Degos L, Chomienne C, Daniel MT, Berger R, Dombret H, Fenaux P, Castaigne S: Treatment of first relapse in acute promyelocytic leukaemia with all trans retinoic acid. Lancet 2:1440, 1990
31. Warrel RP, Frankel SR, Miller W, Itri L, Andreeff M, Jabukowski A, Gabrilove J, Gordon MS, Dmitrovsky E: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all trans retinoic acid). N Engl J Med 324:1385, 1991
32. Chen ZX, Xue YQ, Zhang R, Tao RF, Xia XM, Li C, Wang W, Zu WY, Yao XZ, Ling BJ: A clinical and experimental study on all trans retinoic acid treated acute promyelocytic leukemia patients. Blood 78:1413, 1991
33. Elliott S, Taylor K, White S, Marlton P, Wiley J, Wright S, Timms P: Proof of differentiating mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis. Blood 79:1916, 1991
34. Ohashi H, Ichikawa A, Takagi N, Hotta T, Naoe T, Ohno R, Saito H: Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: Molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone. Leukemia 6:859, 1992
35. Fenaux P, Castaigne S, Chomienne C, Dombret H, Degos L: All trans retinoic acid treatment for patients with acute promyelocytic leukemia. Leukemia 6:64, 1992
36. Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell R: The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med 117:292, 1992
37. Wang ZY, Sun GL, Lu JX, Gu LJ, Huang ME, Chen SR: Treatment of acute promyelocytic leukemia with all-trans retinoic acid in China. Nouv Rev Fr Hematol 32:34, 1990
38. Sun G, Ouyang R, Chen S, Gu Y, Huang L, Lu J, Wang Z: Follow up of 481 patients with APL after CR using ATRA. Chin J Hematol 15:411, 1994
39. Sun GL, Zhou RF, Wu W, Jiang GS: Follow up of 524 APL patients after CR induced by ATRA. Leukemia 8:1082, 1994 (abstr)
40. Ohno R, Yoshida H, Fukutani H, Naoe T, Ohshima T, Kyo T, Endoh N, Fujimoto T, Kobayashi T, Hiraoka A, Mizoguchi H, Kodera Y, Suzuki H, Hirano M, Akiyama H, Aoki N, Shindo H, Yokomaku S, the Leukemia Study Group of the Ministry of Health and Welfare: Multi-institutional study of all-trans retinoic acid as a differentiation therapy of refractory acute promyelocytic leukemia. Leukemia 7:1722, 1993
41. Frankel SR, Eardley A, Heller G, Berman E, Miller WH, Dmitrovsky E, Warrell RP: All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York study. Ann Intern Med 120:279, 1994
42. Warrell RP, Maslak P, Eardley A, Heller G, Miller WH, Frankel SR: Treatment of acute promyelocytic leukemia with all-trans retinoic acid: An update of the New York experience. Leukemia 8:926, 1994
43. White KL, Wiley JS, Frost T, McKendrick JJ, Hermann RP, Seldon M, Enno A, Bell R, Bunce I, Taylor K, Morgan M, Edwards L, Firskin FC: All-trans retinoic acid in the treatment of acute promyelocytic leukaemia. Aust NZ J Med 22:449, 1992
44. Delva L, Cornic M, Balitrand N, Guidez F, Miclea JM, Delmer A, Teillet F, Fenaux P, Castinge S, Degos L, Chomienne C: Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: Study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood 82:2175, 1993
45. Fenaux P, Chastang C, Chomienne C, Degos L: Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemia. Lancet 343:1033, 1994
46. Fenaux P, Castaigne S, Dombret H, Archimbaud E, Duarte M, Morel P, Lamy T, Tilly H, Guerci A, Maloisel F, Bordessoule D, Sadoun A, Tiberghien P, Fegueux N, Daniel MT, Chomienne C, Degos L: All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: A pilot study on 26 cases. Blood 80:2176, 1992
47. Fenaux P, Wattel E, Archimbaud E, Sanz M, Hecquet B, Guerci A, Link H, Fegueux N, Fey M, Castaigne S, Degos L: Prolonged follow up confirms that all transretinoic acid (ATRA) followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia (APL). Blood 84:666, 1994
48. Ohno R, Tanimoto M, Murakami H, Kanamaru A, Asou N, Kobayashi T, Kuriyama K, Ohmoto E, Sakamaki H, Tsubaki K, Hiraoka A, Yamada O, Oh H, Furusawa S, Matsuda S: Treatment of newly diagnosed acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA). Proc Am Soc Clin Oncol 13:303, 1994 (abstr, suppl)
49. Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H, Guerci A, Duarte M, Daniel MT, Bowen D, Huebner G, Bauters F, Fegeuex N, Fey M, Sanz M, Lowenberg B, Maloisel F, Auzanneau G, Sadoun A, Gardin C, Bastion Y, Ganser A, Jacky E, Dombret H, Chastang C, Degos L, the European APL 91 Group: Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood 82:3241, 1993
50. Breitman TR, Collins SJ, Keene BR: Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 57:1000, 1981
51. Chomienne C, Balitrand N, Abita JP: Inefficacy of the synthetic aromatic retinoid etretinate and of its free acid on the in vitro differentiation of leukemic cells. Leuk Res 10:1079, 1986
52. Chomienne C, Balitrand N, Cost H, Degos L, Abita JP: Structure-activity relationships of the aromatic retinoids on the differentiation of the human histiocytic lymphoma cell line U-937. Leuk Res 10:1301, 1986
53. Douer D, Koeffler HP: Retinoic acid: Inhibition of the clonal growth of human myeloid leukemia cells. J Clin Invest 69:27, 1982
54. Imaizumi M, Breitman TR: Retinoic acid induced differentiation of the human promyelocytic leukemia cell line, HL-60, and fresh human, leukemia cells in primary culture: A model for differentiation inducing therapy. Eur J Haematol 38:1986, 1987
55. Chomienne C, Ballerini P, Balitrand N, Amar M, Bernard JF, Boivin P, Daniel MT, Berger R, Castaigne S, Degos L: Retinoic acid therapy for promyelocytic leukemia. Lancet 147:746, 1989
56. Agadir A, Comic C, Lefebvre P, Gourmel B, Balitrand N, Degos L, Chomienne C: Differential uptake of all-trans retinoic acid by acute promyelocytic leukemic cells: Evidence for its role in retinoic acid efficacity. Leukemia (in press)
57. Chomienne C, Barbey S, Balitrand N, Degos L, Sachs L: Regulation of Bcl-2 and cell death by all-trans retinoic acid in acute promyelocytic leukemia cells. Proc Am Ass Cancer Res 33:41, 1992 (abstr)
58. Fontana JA, Rogers JS, Durham JP: The role of 13cis retinoic acid in the remission induction of a patient with acute promyelocytic leukemia. Cancer 57:209, 1986
59. Peck R, Bollag W: Potentiation of retinoid induced differentiation of HL60 and U937 cell lines by cytokines. Eur J Cancer 27:53, 1991
60. Dubois C, Schlageter MH, De Gentile A, Guidez F, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, Degos L, Chomienne C: Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. Blood 83:3264, 1994
61. Gratas C, Menot ML, Dresch C, Chomienne C: Retinoic acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells. Leukemia 7:1156, 1993
62. Miclea JM, Chomienne C: Effect of all trans retinoic acid on CD34+ human myeloid cells. Leukemia 8:214, 1994
63. Daniel MT, Koken M, Romagne O, Barbey S, Bazarbachi A, Stadler M, Guillemin MC, Degos L, Chomienne C, de The H: PML protein expression in haematopoietic and APL cells. Blood 82:1858, 1993
64. Koken MHM, Puvion-Dutilleul F, Guillemin MC, Viron A, Linaret-Cruz G, Stuurman W, de Jong L, Szostecki C, Calvo F, Chomienne C, Degos L, Puvion E, de The H: The t(15;17) translocation alters a nuclear body in a retinoic and reversible fashion. EMBO J 13:1073, 1994
65. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmofonseca M, Lamond A, Dejean A: Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell 76:345, 1994
66. Dyck JA, Maul GG, Miller WH, Don Chen J, Kakizuka A, Evans RM: A novel macromolecular structure is a target of the promyelocytic retinoic acid receptor oncoprotein. Cell 76:333, 1994
67. Dubois C, Schlageter MH, de Gentile A, Guidez F, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, Degos L, Chomienne C: Modulation of IL-6 and IL-1β and G-CSF secretion by all trans retinoic acid in acute promyelocytic leukemia. Leukemia 8:1750, 1994
68. de Gentile A, Toubert ME, Dubois C, Krawice I, Schlageter MH, Balitrand N, Castaigne S, Degos L, Rain JD, Najean Y, Chomienne C: Induction of high-affinity GM-CSF receptors during alltrans retinoic acid treatment of acute promyelocytic leukemia. Leukemia 8:1758, 1994
69. Geiger S, Dombret H, Merle Beral H, Bucherer C, Lacombe C, Lelievre JC: Study of microrheological properties of acute promyelocytic leukemia cells during all-trans retinoic acid therapy. Br J Haematol 87:9, 1994 (abstr, suppl 1)
70. Stadler M, Ganser A, Hoelzer D: Acute promyelocytic leukemia. N Engl J Med 330:140, 1994
71. Speiser W, Pabinger-Fashing I, Kyrle PA, Kapiotis S, Kottas-Heldenberg A, Bettelheim P, Lechner K: Hemostatic and fibrinolytic parameters in patients with acute myeloid leukemia: Activation of blood coagulation, fibrinolysis and unspecific proteiolysis. Blut 61:298, 1990
72. Scbwartz BS, Williams EC, Conlan MG, Mosher MG: Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency. Ann Intern Med 105:873, 1986
73. Avvisatti G, Ten Gate JW, Buller HR, Mandelli F: Tranexamic acid for control of hemorrhage in acute promyelocytic leukemia. Lancet 2:122, 1989
74. Dombret H, Scrobohaci ML, Daniel M, Micléa JM, Castaigne S, Chomienne C, Fenaux P, Degos L: In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): Effect of all-trans retinoic acid (ATRA) therapy. Leukemia (in press)
75. Dombret H, Renesto P, Scrobohaci ML, Guerci AP, Baruchel A, Molina L, Rapp MJ, Cordonnier C, Castaigne S, Degos L: Plasma free serine protease activity (SPA) in patients with acute promyelocytic leukemia (APL): Effect of all trans retinoic acid (ATRA) therapy. Blood 82:249a, 1993 (abstr, suppl 1)
76. Tapiovaara H, Matikainen S, Hurme M, Vaheri A: Induction of differentiation of promyelocytic NB4 cells by retinoic acid is associated with rapid increase in urokinase activity subsequently downregulated by production of inhibitors. Blood 83:1883, 1994
77. Federici AB, Berkowitz SD, Lattuada A, Mannucci PM: Degradation of von Willebrand factor in patients with acquired clinical conditions in which there is heightened proteolysis. Blood 81:720, 1993
78. Dombret H, Scrobohaci ML, Ghorra P, Zini JM, Daniel MT, Castaigne S, Degos L: Coagulation disorders associated with acute promyelocytic leukemia: Corrective effect of all-trans retinoic acid treatment. Leukemia 7:2, 1993
79. Runde V, Aul C, Sudhoff T, Heyll A, Schneider W: Retinoic acid in the treatment of acute promyelocytic leukemia: Inefficacy of the 13-cis isomer and induction of complete remission by the all-trans isomer complicated by thromboembolic events. Ann Hematol 64:270, 1993
80. Forjaz De Lacerda J, Alves Do Carmo J, Lurdes Guerra M, Geraldes J, Forjaz De Lacerda JM: Multiple thrombosis in acute promyelocytic leukaemia after tretinoin. Lancet 342:114, 1993
81. Hashimoto S, Koike T, Tatewaki W, Seki Y, Sato N, Azegami T, Tsukada N, Takahashi H, Kimura H, Ueno M, Arakawa M, Shibata A: Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage. Leukemia 8:1113, 1994
82. Mahmoud HH, Hurwitz CA, Roberts WM, Santana VM, Ribeiro RC, Krance RA: Tretinoin toxicity in children with acute promyelocytic leukaemia. Lancet 342:1394, 1993
83. Akiyama H, Nakamura N, Nagasaka S, Sakamaki H, Onozawa Y: Hypercalcaemia due to all-trans retinoic acid. Lancet 1:308, 1992
84. Hakimian D, Tallman MS, Zugerman C, Caro WA: Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Leukemia 7:758, 1993
85. Koik T, Tatewaki W, Aoki A, Yoshimoto H, Yagisawa K, Hashimoto S, Furukawa T, Saitoh H, Takahashi M, Li-Bo Y, Ying W, Shibata A: Brief report: Severe symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with tretinoin (all trans retinoic acid). N Engl J Med 327:385, 1992
86. Iwakiri R, Inokuchi K, Dan K, Nomura T: Marked basophilia in acute promyelocytic leukaemia treated with all-trans retinoic acid: Molecular analysis of the cell origin of the basophils. Br J Haematol 86:870, 1994
87. Lefebvre P, Thomas G, Gourmel B, Dreux C, Castaigne S, Chomienne C: Pharmacokinetics of all-trans RA in patients with acute promyelocytic. Leukemia 5:1054, 1991
88. Muindi J, Frankel SR, Miller WH, Jakubowski A, Scheinberg DA, Young CW, Dimitrovsky E: Continuous treatment with all-trans RA progressively decreases plasma drug concentrations: Implications for relapse and resistance in acute promyelocytic leukemia. Blood 79:299, 1992
89. Muindi JRF, Frankel SR, Huseltion C, DeGrazia F, Garland WA, Young CW, Warrell RP: Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res 52:2138, 1992
90. Cornic M, Delva L, Guidez F, Balitrand N, Degos L, Chomienne C: Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients. Cancer Res 52:3329, 1992
91. Adamson PC, Boylan JF, Balis FM, Murphy RF, Godwin KA, Gudas LJ, Poplack DG: Time course of induction of metabolism ol all trans retinoic acid and the up regulation of cellular retinoic acid binding protein. Cancer Res 53:472, 1993
92. Li YP, Said F, Gallagher RE: Retinoic acid resistant HL-60 cells exclusively contain mutant retinoic acid receptor α. Blood 83:3298, 1994
93. Dermime S, Grignani F, Clerici M, Nervi C, Sozzi G, Talamo GP, Marchesi E, Formelli F, Parmiani G, Pelicci PG, Gambacorti-Passerini C: Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the PML/RARα protein. Blood 82:1573, 1993
94. Warrell RP: Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies and implications. Blood 82:1949, 1993
95. Miller VA, Rigas JR, Muindi JRF, Tong WP, Venkatraman E, Kris MG, Warrell RP: Modulation of all-trans retinoic acid pharmacokinetics by liarozole. Cancer Chemother Pharmacol (in press)
96. Rigas JR, Francis PA, Muindi JRF, Kris MG, Huselton C, DeGrazia F, Orazem JP, Young CW, Warrell RP: Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid and its modulation by ketoconazole. J Natl Cancer Inst 85:1921, 1993
97. Koller E, Krieger O, Kaspary H, Lutz D: Restoration of all-trans retinoic acid sensitivity by interferon in acute promyelocytic leukaemia. Lancet 388:1154, 1991
98. Dawson MI, Elstner E, Kizaki M, Chen DL, Pakkala S, Kerner B, Koeffler P: Myeloid differentiation mediated through retinoic acid receptor/retinoic x receptor not RXR/RXR Pathway. Blood 84:446, 1994
99. Vaichus L, Villalona-Calero MA, Caliguiri T: Acute progranulocytic leukemia (APL): Possible in vivo differentiation by granulocyte colony-stimulating factor. (G-CSF). Leukemia 7:1680, 1993
100. Nakajima K, Hatake K, Miyata T, Muroi K, Komatsu N, Miura Y: Acute promyelocytic leukaemia, tretinoin and granulocyte colony-stimulating factor. Lancet 343:173, 1994
101. Biondi A, Rambaldi A, Pandolfi PP, Rossi V, Guidici G, Alcalay M, Lo Coco F, Diverio D, Pogliani EM, Lanzi EM, Mandelli F, Masera G, Barbui T, Pelicci PG: Molecular monitoring of the myl/retinoic acid receptor alpha fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood 80:492, 1992
102. Castaigne S, Balitrand N, de The H, Dejean A, Degos L, Chomienne C: A PML/RARα fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. Blood 79:3110, 1992
103. Miller WH, Levine K, DeBlasio A, Frankel SR, Dmitrovsky E, Warrell RP: Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for PML-RARa fusion mRNA. Blood 82:1689, 1993
104. Ikeda K, Sasaki K, Tasaka T, Nagai M, Kawanishi K, Takahara J, Irino S: Reverse transcription polymerase chain reaction for PML-RARα fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection. Leukemia 7:544, 1993
105. Diverio D, Pandolfi PP, Rossi V, Biondi A, Pelicci PG, Lo Coco F: Monitoring of treatment outcome in acute promyelocytic leukemia by RT-PCR. Leukemia 8:1105, 1994
106. Diverio D, Pandolfi PP, Biondi A, Avvisati G, Petti MC, Mandelli F, Pelicci PG, Lo Coco F: Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remission. Blood 82:3556, 1993
107. Laczika K, Mitterbauer G, Korninger L, Knobl P, Scharzinger I, Kapiotis S, Haas OA, Kyrle PA, Pont J, Oehler L: Rapide achievement of PML-RAR polymerase chain reaction (PCR)-negativity by combined treatment with all trans-retinoic acid and chemotherapy in acute promyelocytic leukemia: A pilot study. Leukemia 8:1, 1994
108. Biondi A, Rovelli A, Cantu-Rajnoldi A, Fenu S, Basso G, Luciano A, Rondelli R, Mandelli F, Masera G, Testi AM: Acute promyelocytic leukemia in children: Experience of the Italian pediatric hematology and oncology group (AIEOP). Leukemia 8:1264, 1994
109. Claston DF, Reading CL, Nagarajan L, Tsujimoto Y, Andersson BS, Estey E, Cork A, Huh YO, Trujillo J, Deisseroth AB: Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood 80:582, 1992
110. Castaigne S, Lefebvre P, Chomienne C, Sue E, Rigal-Huguet F, Gardin C, Delmer A, Archimbaud E, Tilly H, Janvier M, Isnard F, Travade P, Montfort L, Delannoy A, Rapp MJ, Christian B, Montastruc M, Weh H, Penaux P, Dombret H, Gourmel B, Degos L: Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia. Blood 82:3560, 1993
111. Mandelli F, Labopin M, Granena A, Iriondo A, Prentice G, Bacigalupo A, Sierra J, Meloni G, Frassoni F, Golman J, Gratwohl A, Gorin NC, and EBMT: European Survey of bone marrow transplantation in acute promyelocytic leukemia (M3). Bone Marrow Transplant 14:293, 1994
112. Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik PH: The immunophenotype of acute promyelocytic leukemia (APL): An ECOG study. Leukemia 8:1108, 1994
113. Chomienne C, Ballerini P, Balitrand N, Krawice I, Fenaux P, Castaigne S, de Thé H, Degos L: Normal RARα gene transcripts are modulated during RA induced granulocytic differentiation in APL cells. J Clin Invest 88:2150, 1991
114. Fenaux P, Chastang C, Castaigne S, Archimbaud E, Sanz M, Link H, Guerci A, Fegueux N, Zittoun R, Stoppa AM, Travade P, Lamy T, Maloisel F, Sadoun A, San Miguel J, Veil A, Rayon C, Conde E, Fey M, Bordessoule D, Ganzer A, Bowen D, Dreyfus F, Huguet F, Tilly H, Guy H, Auzanneau G, Chomienne C, Degos L: Treatment of newly diagnosed acute promyelocytic leukemia (APL) with all transretinoic acid (ATRA) followed by intensive chemotherapy (CT). Updated results of the European group. Blood 84:379a, 1994 (abstr, suppl)
115. Avvisati G, Baccarini M, Ferrara F, Lazzarino M, Resegotti L, Mandelli F: AIDA protocol (all-trans retinoic acid + idarubicin) in the treatment of newly diagnosed acute promyelocytic leukemia (APL): A pilot study of the Italian cooperative group GIMEMA. Blood 84:380a, 1994 (abstr, suppl)